Applied Clinical Trials-09-01-2023

Experts weigh in on the latest advances and adoption trends.

Approaching protocol design and operational planning with patient empathy.

How advanced ePRO tools and approaches offer a path forward.

Steve Rosenberg, CEO of uMotif gives commentary on providing clinical trial patients with the best experience possible.

Investigating more objectively measured 'structural' characteristics.

Overall rate of significant KRI results for sites located in Ukraine has consistently risen since 2021.

Intended use must not replace the clinical decision-making process.

In this Q&A, Rohit Nambisan, CEO of Lokavant, and Craig Lipset, founder of Clinical Innovation Partners and Lokavant advisory board member, brief ACT on what current uses of real-world data and analytics can mean to clinical trial execution.

MJH Life Sciences, parent company of Applied Clinical Trials, continues to offer many forms of educational content to healthcare professionals.

Area of concern for oncology researchers must be addressed so trials can reflect a more accurate real-world population.

With lessons from COVID now established, concrete ideas on improving drug development strategy for future health threats are beginning to take shape.